OraSure Technologies Inc (OSUR) Com Stk Npv

Sell:$3.22Buy:$3.23$0.12 (3.56%)

NASDAQ:5.97%
Market closed | Prices delayed by at least 15 minutes
Sell:$3.22
Buy:$3.23
Change:$0.12 (3.56%)
Market closed | Prices delayed by at least 15 minutes
Sell:$3.22
Buy:$3.23
Change:$0.12 (3.56%)
Market closed | Prices delayed by at least 15 minutes

Company Information

About this company

OraSure Technologies, Inc. provides point-of-care and home diagnostic tests and sample management solutions. The Company's product portfolio is divided into diagnostics products and sample management solutions. Its business consists of the development, manufacture, marketing and sale of diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. Its diagnostic products include tests for diseases including COVID-19, HIV, Hepatitis C and Syphilis that are performed on a rapid basis at the point of care, and tests for drugs of abuse that are processed in a laboratory. Its business also includes sample management solutions and services that are used by clinical laboratories, direct-to-consumer laboratories, researchers, pharmaceutical companies, and animal health service and product providers.

Key people

Carrie Eglinton Manner
President, Chief Executive Officer, Director
Kenneth J. Mcgrath
Chief Financial Officer
Kathleen Gallagher Weber
Chief Product Officer
Mara Glickman Aspinall
Independent Chairman of the Board
James Anthony Datin
Independent Director
Nancy J. Gagliano
Independent Director
John P Kenny
Independent Director
Lelio Marmora
Independent Director
Click to see more

Key facts

  • EPIC
    OSUR
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US68554V1089
  • Market cap
    $252.08m
  • Employees
    501
  • Shares in issue
    74.80m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.